<DOC>
	<DOCNO>NCT00014391</DOCNO>
	<brief_summary>RATIONALE : Antivirals ribavirin use treat infection cause virus . It yet know ribavirin effective without monoclonal antibody therapy treat patient develop RSV pneumonia follow peripheral stem cell transplantation . PURPOSE : Randomized phase III trial compare effectiveness ribavirin without monoclonal antibody treat patient develop RSV pneumonia follow peripheral stem cell transplantation .</brief_summary>
	<brief_title>Ribavirin With Without Monoclonal Antibody Therapy Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation</brief_title>
	<detailed_description>OBJECTIVES : I . Compare efficacy , term all-cause mortality reduction , ribavirin without palivizumab patient respiratory syncytial virus pneumonia follow stem cell transplantation . II . Determine safety treatment patient population . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord prior ribavirin exposure infection ( 24 hour vs less 24 hour ) requirement ventilator support ( yes v ) . Patients randomize one two treatment arm . Arm I : Patients receive aerosolize ribavirin via face mask oxygen tent 2 hour 3 time daily 16-18 hour day 1-10 palivizumab IV 2 hour ribavirin administration day 1 . Arm II : Patients receive aerosolize ribavirin arm I placebo IV 2 hour ribavirin administration day 1 . Patients follow 14 , 21 , 28 day . PROJECTED ACCRUAL : A total 140 patient ( 70 per arm ) accrue study within 2 year .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Palivizumab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Confirmed respiratory syncytial virus ( RSV ) pneumonia document rapid antigen test ( ELISA IFA ) , shell vial culture bronchoalveolar lavage specimen , tissue antigen stain lung biopsy sample New infiltrate chest xray least one following : Cough Wheezing Dyspnea and/or tachypnea ( great 150 % baseline ) Oxygen saturation le 90 % two occasion 1 hour apart room air Arterial oxygen pressure le 80 No 60 hour since confirmation pneumonia chest xray Received prior stem cell transplantation meet one following : Between start conditioning ( preparative ) regimen day 90 allogeneic , autologous , syngeneic stem cell transplantation ( SCT ) Between day 91 180 unrelated HLA mismatchrelated allogeneic SCT ( bone marrow , peripheral blood stem cell ( PBSC ) , cord blood ) , Tcell deplete allogeneic transplantation , CD34 select allogeneic PBSC transplantation Between day 91 180 SCT graftversushost disease require systemic steroid expect continue throughout study Other pulmonary pathogen addition RSV allow PATIENT CHARACTERISTICS : Age : Any age Performance status : Not specify Life expectancy : At least 48 hour Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No prior adverse reaction ribavirin palivizumab No allergy monoclonal antibody HIV negative Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 3 month study PRIOR CONCURRENT THERAPY : Biologic therapy : See Disease Characteristics At least 3 month since prior immunotherapy respiratory syncytial virus ( RSV ) include RSV hyperimmune globulin RSV monoclonal antibody Concurrent IV immunoglobulin allow No prior experimental RSV vaccine No concurrent RSV hyperimmune globulin No concurrent RSVspecific monoclonal antibody Chemotherapy : Not specify Endocrine therapy : See Disease Characteristics Radiotherapy : Not specify Surgery : Not specify Other : At least 4 week since prior investigational product respiratory viral disease At least 3 month since prior antiviral drug specific antiRSV activity Prior aerosolize ribavirin allow No concurrent antiviral drug specific antiRSV activity Concurrent ganciclovir foscarnet allow Ventilator support allow</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
	<keyword>recurrent cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>refractory multiple myeloma</keyword>
	<keyword>recurrent childhood rhabdomyosarcoma</keyword>
	<keyword>stage II ovarian epithelial cancer</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>recurrent Wilms tumor childhood kidney tumor</keyword>
	<keyword>stage I multiple myeloma</keyword>
	<keyword>stage II multiple myeloma</keyword>
	<keyword>stage III multiple myeloma</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>stage III chronic lymphocytic leukemia</keyword>
	<keyword>stage IV chronic lymphocytic leukemia</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>relapse chronic myelogenous leukemia</keyword>
	<keyword>refractory chronic lymphocytic leukemia</keyword>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>chronic phase chronic myelogenous leukemia</keyword>
	<keyword>accelerated phase chronic myelogenous leukemia</keyword>
	<keyword>blastic phase chronic myelogenous leukemia</keyword>
	<keyword>meningeal chronic myelogenous leukemia</keyword>
	<keyword>chronic idiopathic myelofibrosis</keyword>
	<keyword>childhood acute promyelocytic leukemia ( M3 )</keyword>
	<keyword>testicular embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma</keyword>
	<keyword>testicular teratoma</keyword>
	<keyword>testicular yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma teratoma</keyword>
	<keyword>testicular embryonal carcinoma teratoma seminoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor seminoma</keyword>
	<keyword>testicular embryonal carcinoma seminoma</keyword>
	<keyword>testicular yolk sac tumor teratoma</keyword>
	<keyword>testicular yolk sac tumor teratoma seminoma</keyword>
	<keyword>testicular choriocarcinoma yolk sac tumor</keyword>
	<keyword>testicular choriocarcinoma embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma teratoma</keyword>
	<keyword>testicular choriocarcinoma seminoma</keyword>
	<keyword>refractory hairy cell leukemia</keyword>
	<keyword>recurrent/refractory childhood Hodgkin lymphoma</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>ovarian yolk sac tumor</keyword>
	<keyword>ovarian embryonal carcinoma</keyword>
	<keyword>ovarian polyembryoma</keyword>
	<keyword>ovarian choriocarcinoma</keyword>
	<keyword>ovarian immature teratoma</keyword>
	<keyword>ovarian mature teratoma</keyword>
	<keyword>ovarian monodermal highly specialized teratoma</keyword>
	<keyword>ovarian mixed germ cell tumor</keyword>
	<keyword>stage III grade 1 follicular lymphoma</keyword>
	<keyword>stage III grade 2 follicular lymphoma</keyword>
	<keyword>stage III grade 3 follicular lymphoma</keyword>
	<keyword>stage III adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult lymphoblastic lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>secondary acute myeloid leukemia</keyword>
	<keyword>de novo myelodysplastic syndrome</keyword>
	<keyword>poor prognosis metastatic gestational trophoblastic tumor</keyword>
	<keyword>previously treat myelodysplastic syndrome</keyword>
	<keyword>secondary myelodysplastic syndrome</keyword>
	<keyword>infection</keyword>
	<keyword>pulmonary complication</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
	<keyword>noncontiguous stage II grade 1 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 2 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 3 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>noncontiguous stage II mantle cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>noncontiguous stage II adult lymphoblastic lymphoma</keyword>
	<keyword>stage III mantle cell lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>previously treat childhood rhabdomyosarcoma</keyword>
	<keyword>noncontiguous stage II small lymphocytic lymphoma</keyword>
	<keyword>noncontiguous stage II marginal zone lymphoma</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>stage III small lymphocytic lymphoma</keyword>
	<keyword>stage III marginal zone lymphoma</keyword>
	<keyword>stage IV small lymphocytic lymphoma</keyword>
	<keyword>stage IV marginal zone lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
	<keyword>childhood myelodysplastic syndrome</keyword>
</DOC>